BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yao T, Takata M, Tustsumi S, Nishiyama K, Taguchi K, Nagai E, Tsuneyoshi M. Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis. Pathology. 2002;34:556-560. [PMID: 12555994 DOI: 10.1080/0031302021000035965-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Takata M, Yao T, Nishiyama KI, Nawata H, Tsuneyoshi M. Phenotypic alteration in malignant transformation of colonic villous tumours: with special reference to a comparison with tubular tumours. Histopathology. 2003;43:332-339. [PMID: 14511251 DOI: 10.1046/j.1365-2559.2003.01709.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
2 Fujimoto Y, Nakanishi Y, Sekine S, Yoshimura K, Akasu T, Moriya Y, Shimoda T. CD10 Expression in Colorectal Carcinoma Correlates With Liver Metastasis. Diseases of the Colon & Rectum 2005;48:1883-9. [DOI: 10.1007/s10350-005-0141-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
3 Liu AY, Brubaker KD, Goo YA, Quinn JE, Kral S, Sorensen CM, Vessella RL, Belldegrun AS, Hood LE. Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines. Prostate 2004;60:98-108. [PMID: 15162376 DOI: 10.1002/pros.20031] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
4 Oliveira LA, Artigiani-Neto R, Waisberg DR, Fernandes LC, Lima Fde O, Waisberg J. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival. Arq Gastroenterol. 2010;47:361-367. [PMID: 21225146 DOI: 10.1590/s0004-28032010000400008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
5 Nishida T, Egashira Y, Akutagawa H, Fujii M, Uchiyama K, Shibayama Y, Hirose Y. Predictors of lymph node metastasis in T1 colorectal carcinoma: an immunophenotypic analysis of 265 patients. Dis Colon Rectum 2014;57:905-15. [PMID: 25003285 DOI: 10.1097/DCR.0000000000000168] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.9] [Reference Citation Analysis]
6 Bircan S, Candir O, Kapucuoglu N, Serel TA, Ciris M, Karahan N. CD10 Expression in Urothelial Bladder Carcinomas: A Pilot Study. Urol Int 2006;77:107-13. [DOI: 10.1159/000093901] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
7 Mizerska-Dudka M, Kandefer-Szerszeń M. Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them? Arch Immunol Ther Exp (Warsz) 2015;63:197-205. [PMID: 25193979 DOI: 10.1007/s00005-014-0311-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
8 Sasaki T, Kuniyasu H, Luo Y, Fujiwara R, Kitayoshi M, Tanabe E, Kato D, Shinya S, Fujii K, Ohmori H, Yamashita Y. Serum CD10 is associated with liver metastasis in colorectal cancer. Journal of Surgical Research 2014;192:390-4. [DOI: 10.1016/j.jss.2014.05.071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
9 Oshima T, Kawasaki T, Ohashi R, Hasegawa G, Jiang S, Umezu H, Aoyagi Y, Iwanari H, Tanaka T, Hamakubo T. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. Pathol Int. 2007;57:82-90. [PMID: 17300672 DOI: 10.1111/j.1440-1827.2006.02061.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
10 Toya Y, Endo M, Yamada S, Oizumi T, Morishita T, Akasaka R, Yanai S, Nakamura S, Eizuka M, Uesugi N, Sugai T, Matsumoto T. The mucin phenotype does not affect the endoscopic resection outcome of non-ampullary duodenal epithelial tumors. Endosc Int Open 2021;9:E1297-302. [PMID: 34466350 DOI: 10.1055/a-1477-3186] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kumashiro Y, Yao T, Aishima S, Hirahashi M, Nishiyama K, Yamada T, Takayanagi R, Tsuneyoshi M. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol. 2007;38:857-863. [PMID: 17320150 DOI: 10.1016/j.humpath.2006.10.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
12 Koga Y, Hirahashi M, Ohishi Y, Oda Y. Clinicopathological features and phenotypic classification of de novo-type colorectal carcinomas differ from those of colorectal carcinomas derived from flat adenomas. Pathol Int 2019;69:331-40. [PMID: 31282116 DOI: 10.1111/pin.12803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bahadir B, Behzatoglu K, Bektas S, Bozkurt ER, Ozdamar SO. CD10 expression in urothelial carcinoma of the bladder. Diagn Pathol 2009;4:38. [PMID: 19917108 DOI: 10.1186/1746-1596-4-38] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
14 Raposo TP, Comes MS, Idowu A, Agit B, Hassall J, Fadhil W, Nica R, Ecker R, Yao T, Ilyas M. CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer. Experimental and Molecular Pathology 2018;104:190-8. [DOI: 10.1016/j.yexmp.2018.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Uneyama M, Chambers JK, Nakashima K, Uchida K, Nakayama H. Histological Classification and Immunohistochemical Study of Feline Colorectal Epithelial Tumors. Vet Pathol 2021;58:305-14. [PMID: 33208031 DOI: 10.1177/0300985820974279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shiroshita H, Watanabe H, Ajioka Y, Watanabe G, Nishikura K, Kitano S. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int. 2004;54:311-321. [PMID: 15086835 DOI: 10.1111/j.1440-1827.2004.01625.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
17 Fujita S, Taniguchi H, Yao T, Shimoda T, Ueno H, Hirai T, Ohue M. Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression. Int J Colorectal Dis 2010;25:681-6. [DOI: 10.1007/s00384-010-0913-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
18 Bernescu I, Reichstein AC, Luchtefeld M, Ogilvie JW. Does CD10 Expression Predict Lymph Node Metastasis in Colorectal Cancer? Dis Colon Rectum 2016;59:22-7. [PMID: 26651108 DOI: 10.1097/DCR.0000000000000498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Kumagai R, Kohashi K, Takahashi S, Yamamoto H, Hirahashi M, Taguchi K, Nishiyama K, Oda Y. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine. World J Gastroenterol 2015; 21(9): 2700-2710 [PMID: 25759539 DOI: 10.3748/wjg.v21.i9.2700] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
20 Koga Y, Yao T, Hirahashi M, Kumashiro Y, Ohji Y, Yamada T, Tanaka M, Tsuneyoshi M. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence. Histopathology. 2008;52:569-577. [PMID: 18370954 DOI: 10.1111/j.1365-2559.2008.02996.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
21 Tajima Y, Yamazaki K, Nishino N, Morohara K, Yamazaki T, Kaetsu T, Suzuki S, Kawamura M, Kumagai K, Kusano M. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. Br J Cancer 2004;91:1342-8. [PMID: 15354218 DOI: 10.1038/sj.bjc.6602147] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
22 Haase G, Gavert N, Brabletz T, Ben-Ze'ev A. A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10. Oncogene 2017;36:1597-606. [PMID: 27641335 DOI: 10.1038/onc.2016.329] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
23 Mizerska-Kowalska M, Bojarska-Junak A, Jakubowicz-Gil J, Kandefer-Szerszeń M. Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development. Tumour Biol 2016;37:13355-68. [PMID: 27460083 DOI: 10.1007/s13277-016-5248-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
24 Fujita H, Ishido K, Kimura N, Wakiya T, Nagase H, Yoshizawa T, Haga T, Goto S, Kijima H, Hakamada K. A case report of mucinous adenocarcinoma derived from intra-ampullary papillary-tubular neoplasm with a malignant course. Surg Case Rep 2021;7:25. [PMID: 33452648 DOI: 10.1186/s40792-020-01045-y] [Reference Citation Analysis]
25 Katano T, Mizoshita T, Tsukamoto H, Nishie H, Inagaki Y, Hayashi N, Nomura S, Ozeki K, Okamoto Y, Shimura T, Mori Y, Kubota E, Tanida S, Kataoka H, Kuno T, Takahashi S, Joh T. Ectopic Gastric and Intestinal Phenotypes, Neuroendocrine Cell Differentiation, and SOX2 Expression Correlated With Early Tumor Progression in Colorectal Laterally Spreading Tumors. Clin Colorectal Cancer 2017;16:141-6. [PMID: 27816419 DOI: 10.1016/j.clcc.2016.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Liu AY, Roudier MP, True LD. Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol 2004;165:1543-56. [PMID: 15509525 DOI: 10.1016/S0002-9440(10)63412-8] [Cited by in Crossref: 95] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
27 Kuniyasu H. Multiple roles of angiotensin in colorectal cancer. World J Clin Oncol 2012; 3(12): 150-154 [PMID: 23293754 DOI: 10.5306/wjco.v3.i12.150] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
28 Hirano K, Nimura S, Mizoguchi M, Hamada Y, Yamashita Y, Iwasaki H. Early colorectal carcinomas: CD10 expression, mucin phenotype and submucosal invasion. Pathol Int 2012;62:600-11. [PMID: 22924846 DOI: 10.1111/j.1440-1827.2012.02850.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
29 Saghatelian A, Jessani N, Joseph A, Humphrey M, Cravatt BF. Activity-based probes for the proteomic profiling of metalloproteases. Proc Natl Acad Sci U S A 2004;101:10000-5. [PMID: 15220480 DOI: 10.1073/pnas.0402784101] [Cited by in Crossref: 340] [Cited by in F6Publishing: 314] [Article Influence: 20.0] [Reference Citation Analysis]
30 Belov L, Zhou J, Christopherson RI. Cell surface markers in colorectal cancer prognosis. Int J Mol Sci 2010;12:78-113. [PMID: 21339979 DOI: 10.3390/ijms12010078] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]